Searched for
CNS MOLECULES
For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...- Zydus Cadila gets permission from DCGI for phase-1 clinical trial of novel molecule ZYIL1Drug firm Zydus Cadila on Monday said it has received permission from Drugs Controller General of India (DCGI) to initiate phase-1 clinical...
- Suven Life gets patents for anti-neuro degeneration moleculeThe molecules are being developed for the treatment of cognitive impairment associated with neuro-degenerative disorders like Alzheimer's d...
- Suven Life gets patent for neuro-degenerative moleculeWith this new patent, Suven has a total of 26 patents from New Zealand. The new patent is valid through 2033, Suven Life Sciences said in a...
- Suven gets patent for CNS molecules from Canada, Hong KongThe new chemical entities (NCEs) are being developed for the treatment of cognitive impairment associated with neuro-degenerative disorders.
- Suven Life gets patents for neuro-degenerative drugWith these new patents, Suven has a total of 24 granted patents from Australia, 17 from Eurasia and 9 from Israel and 24 from the US.
- Suven Life gets patent for neuro-degenerative drugSuven has been granted a patent each by Europe, Hong Kong, Japan, Macau, ARIPO and South Korea for a drug used in the treatment of neuro-de...
- Suven Life gets patent for neuro-degenerative drugWith these new patents, Suven has a total of 22 granted patents from Australia, 19 from China, 17 from Europe, 17 from South Korea and 23 f...
- Suven Life gets patent for chemical molecules to be used in neuro-degenerative drugsIn a BSE filing, the company said that it 'secured patents from China and South Africa to the new chemical entities (NCE) for central nervo...
- Suven Life Sciences shares up over 4 per cent after new patentsShares of Suven Life Sciences rose by 4% after receiving patent from US & S Korea for CNS molecule, used for treating central nervous syste...
- Suven Life gets three patent products for CNS moleculesThe product patents -- two from Canada and one from Eurasia -- are valid through 2028, Suven Life Sciences said in a BSE filing.
- Suven Life gets four patent approvals for CNS moleculesDrug firm Suven Life Sciences today said it has received four product patents for CNS molecules, two from China, one from Mexico and one fr...
- Suven Life gets three patent approvals for CNS moleculesDrug firm Suven Life Sciences today said it has received three product patents for CNS molecules, two from Eurasia and one from Canada.
- Suven gets four new drug molecule patents in four countriesSuven Life Sciences Ltd gets four product patents one each from Australia, Canada, Korea and New Zealand for their new drug molecules (New ...
- TCG ties up with JSW Lifesciences for drug clinical studiesTCG Lifesciences today said it has entered into an agreement with Austria-based JSW Lifesciences for collaboration services in clinical stu...
- Suven Life Sciences gets four patent approvals for CNS moleculesSuven received four product patents for its new chemical entities (NCEs), which could be used to treat CNS disorders.
- Suven Life sciences gets four patent approvals for CNS moleculesSuven Life sciences today said it has received four product patents from different countries for its new chemical entities.
- Lupin's Japanese arm gets nod for 10 productsLupin's Japanese subsidiary Kyowa Pharma has received approvals for 10 products and expects to launch these in July 2008 post NHI listing.
- Torrent Pharma launches 3 new speciality armsAhmedabad-based Torrent Pharmaceuticals on Friday said it has launched three new speciality divisions to cater to niche therapeutic areas o...
- Suven ties up with US-based pharma coSuven Life Sciences Ltd has signed an agreement with US-based pharmaceutical firm Eli Lilly and Company to carryout pre-clinical research f...
Load More
